Molecular compounds inducing liver injury present major safety concerns while assessing ADMET properties for drugs. In this endpoint, a large dataset of in vivo hepatotoxicity was retrieved from the literature (e.g., DrugBank) by the authors. Clinical information was accessed through PharmaPendium and enhanced by Leadscope. Only information about hepatotoxicity or non-hepatotoxicity in humans was considered.